NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Medical Officer David Lebwohl sold $308K of Intellia Therapeutics, Inc.
Sold$308,249
$128.44Price
2,400Shares
−22%Stake
What NTLA did after the filing
- The stock from Fri, Oct 15 close, $130.49
- −14.4%
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Nov 29 close.
Traded Thu, Oct 14. Filed Fri, Oct 15, 3:02 PM ET, during the session. Returns use the Oct 15 close and the Nov 29 close. Not investment advice.